ScreenerHero
PRMProteome Sciences plc
LSE · GB · Healthcare · Diagnostics & Research · proteomics.com
1.700GBP-5.29%Mkt Cap: 7.65M $P/E: —

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The compa…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap7.65M $
Enterprise Value26.87M $
Revenue (TTM)4.82M $
Gross Profit-103.89K $
Net Income (TTM)-3.93M $
Revenue/Share0.0167 USD
Last Price1.700 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees32
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.43
EV/Revenue5.58
P/S1.49
P/B-0.50
EPS (TTM)-0.01
EPS (Forward)—
52W Range
1.20016% of range4.400
52W High4.400 GBP
52W Low1.200 GBP
Profitability
Gross Margin-2.16%
Oper. Margin-54.98%
EBITDA Margin-66.19%
Profit Margin-81.50%
ROE32.12%
ROA-37.08%
Growth
Revenue Growth-28.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-59.00K $
CapEx (TTM)124.41K $
FCF Margin-10.15%
FCF Yield-6.40%
Net Debt19.23M $
Net Debt/EBITDA-6.03
Balance Sheet
Debt/Equity-1.65
Current Ratio0.13
Quick Ratio0.09
Book Value/Sh-0.0320 GBP
Cash/Share0.0020 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.350.72M
Float221.68M
Insiders18.08%
Institutions24.22%
Technical
SMA 501.747 (-2.7%)
SMA 2001.882 (-9.7%)
Beta0.16
S&P 52W Chg18.16%
Avg Vol (30d)270.26K
Avg Vol (10d)209.32K
Technical Indicators
RSI (14)43.5
MACD0.0046
MACD Signal0.0210
MACD Hist.-0.0164
BB Upper1.927 GBP
BB Middle1.817 GBP
BB Lower1.708 GBP
BB Width12.10%
ATR (14)0.4201 GBP
Vol Ratio (20d)3.25x